In a recent study of older patients with end-stage kidney disease living in Europe, researchers found o ne-third received an ...
Expanded case series includes advanced thymic carcinoma, small cell lung cancer, pancreatic cancer, end-stage liver cirrhosis ...
Living benefits let you access your own life insurance death benefit while still alive if you qualify ...
Travere Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients aged 8 years and ...
In an interview with Targeted Oncology, Naomi Haas, MD, discusses the evolving landscape of adjuvant and neoadjuvant immune ...
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing ...
Cancer cases are surging across all age groups, raising serious public health concerns in India and lifestyle changes, ...
Amid a national kidney shortage, a Bay Area priest faced years waiting for a donation. Then he found charity from an ...
SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to ...
The new 2026 American Heart Association (AHA) guidelines note 9 key steps to better heart health, which include more ...
In today's Pharmaceutical Executive Daily, AbbVie licenses a portfolio of pain compounds from China's Haisco Pharmaceutical ...